Back to top
more

Merck KGaA (MKGAF)

(Delayed Data from OTC)

$175.03 USD

175.03
6

-6.97 (-3.83%)

Updated Aug 2, 2024 11:43 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (154 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for MKGAF

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Merck KGaA falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 2,685 2,292 2,453 1,691 939
Receivables 4,845 4,804 4,896 4,273 4,566
Notes Receivable 0 0 0 0 0
Inventories 5,019 4,881 4,614 3,763 3,743
Other Current Assets 865 878 1,029 875 837
Total Current Assets 13,413 12,855 12,993 10,601 10,083
Net Property & Equipment 9,801 8,643 8,538 7,335 6,959
Investments & Advances 1,065 1,011 1,081 106 827
Other Non-Current Assets 40 39 41 29 25
Deferred Charges 1,639 1,380 1,777 1,763 1,592
Intangibles 26,404 27,095 29,123 26,972 29,474
Deposits & Other Assets 124 104 112 939 109
Total Assets 52,486 51,127 53,668 47,744 49,068
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 2,754 2,632 2,816 2,020 2,300
Current Portion Long-Term Debt 760 1,294 2,994 2,692 5,096
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 1,551 1,562 1,681 1,668 1,570
Other Current Liabilities 4,350 4,536 4,851 4,166 4,296
Total Current Liabilities 9,415 10,023 12,342 10,545 13,263
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,223 1,348 1,669 1,646 2,047
Convertible Debt 0 0 0 0 0
Long-Term Debt 9,999 9,693 9,784 11,177 9,681
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2,892 2,664 4,536 4,938 4,013
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 23,530 23,728 28,332 28,305 29,006
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 612 595 668 645 2,850
Capital Surplus 4,128 4,018 4,512 4,357 4,272
Retained Earnings 21,893 19,453 17,905 14,139 12,888
Other Equity 2,325 3,334 2,250 297 54
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 28,956 27,399 25,337 19,439 20,064
Total Liabilities & Shareholder's Equity 52,486 51,127 53,668 47,744 49,068
Total Common Equity 28,956 27,399 25,337 19,439 20,064
Shares Outstanding NA 129.20 129.20 129.20 129.20
Book Value Per Share -0.29 212.07 196.11 150.45 155.29

Fiscal Year End for Merck KGaA falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 2,697 2,685 2,811 2,101
Receivables NA 4,975 4,845 5,169 5,146
Notes Receivable NA 0 0 0 0
Inventories NA 5,120 5,019 5,410 5,448
Other Current Assets NA 1,130 865 1,374 1,501
Total Current Assets NA 13,922 13,413 14,764 14,196
Net Property & Equipment NA 10,004 9,801 9,490 9,152
Investments & Advances NA 1,163 1,065 1,081 1,138
Other Non-Current Assets NA 39 40 36 35
Deferred Charges NA 1,694 1,639 1,431 1,459
Intangibles NA 26,776 26,404 27,408 27,115
Deposits & Other Assets NA 150 124 104 96
Total Assets NA 53,746 52,486 54,318 53,192
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 2,265 2,754 2,442 2,620
Current Portion Long-Term Debt NA 2,314 760 1,805 1,843
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 1,699 1,551 1,721 1,623
Other Current Liabilities NA 4,513 4,350 3,486 3,560
Total Current Liabilities NA 10,791 9,415 9,453 9,646
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 1,158 1,223 1,234 1,289
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 8,493 9,999 10,383 10,353
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 2,892 2,451 2,711
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 23,267 23,530 23,523 24,000
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 613 612 615 616
Capital Surplus NA 4,141 4,128 4,151 4,159
Retained Earnings NA 22,833 21,893 22,542 21,546
Other Equity NA 2,892 2,325 3,488 2,870
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 30,480 28,956 30,795 29,192
Total Liabilities & Shareholder's Equity NA 53,746 52,486 54,318 53,192
Total Common Equity 0 30,480 28,956 30,795 29,192
Shares Outstanding 129.20 129.20 NA NA NA
Book Value Per Share 0.00 235.91 -0.29 -0.31 -0.29